Keisuke Kazama
Papers
7
Total Citations
40
H-Index
5
About
Keisuke Kazama is a leading colorectal surgeon whose research is reshaping the landscape of minimally invasive cancer surgery, with a particular focus on robotic and laparoscopic techniques for rectal and colon cancers. His work centers on optimizing surgical precision, reducing complications, and preserving patient quality of life. Kazama’s major contributions include pioneering a seven-step dissection technique for robotic total mesorectal excision, which standardizes a complex procedure and has garnered 9 citations. He also leads large-scale, prospective studies like the LANDMARC trial (8 citations), which provides critical data on male sexual dysfunction after minimally invasive rectal cancer surgery—a previously understudied area affecting long-term quality of life. His phase II ROBOCOLO trial (7 citations) demonstrated the safety of robotic surgery for right-sided colon cancer, while his research on technically demanding rectal cancer (6 citations) and local recurrence reduction (5 citations) highlights his commitment to improving oncological outcomes. Kazama’s recent multicenter work on anastomotic leakage and the use of C-reactive protein-to-albumin ratios as predictive biomarkers (2 citations) further underscores his drive to integrate evidence-based risk assessment into clinical practice. With a growing citation impact, Kazama is a key figure advancing the safety and efficacy of modern colorectal surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7